About Haohong Pharmaceutical

Haohong (Qihe) Pharmaceutical Technology Co., Ltd. is located in the High-tech Zone of Qihe County, Shandong Province, adjacent to the Yellow River and within the Jinan Economic Circle, enjoying convenient transportation. The company specializes in the R&D and custom production of innovative active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. It passed the ISO 9001:2015 quality management system certification in 2021, was recognized as a Technology-based Small and Medium-sized Enterprise in 2024, and awarded Innovative Small and Medium-sized Enterprise of Shandong Province in 2025.

Haohong has a high-level R&D team and a full range of analytical testing instruments and methods. At present, its production base in Liaocheng is equipped with 30 sets of 3,000–5,000L reactors, with an annual production capacity of 1,000 tons.

The company focuses on the development of active pharmaceutical ingredients and intermediates for anti-cancer, anti-hepatitis C and anti-diabetic therapies, with an emphasis on high-grade intermediates. Its main products include Bicalutamide, Enzalutamide, Apalutamide, Darolutamide, Abemaciclib, Venetoclax, Macitentan, Empagliflozin, Larotrectinib, Apixaban, Rivaroxaban, Ibrutinib, Ceritinib, Pomalidomide, Lenalidomide, Ivacaftor, Tofacitinib, Cabozantinib, Alectinib, etc.

Our products are exported to overseas markets including the United States, Europe, Japan, India, Bangladesh and other regions. The company currently has dozens of high-grade intermediates available for commercial production, and also provides customers with efficient custom synthesis services ranging from gram scale to hundreds of kilograms.

Adhering to the corporate philosophy of "Pragmatism, Innovation, Integrity", Haohong is committed to serving global customers with full dedication!
🎓
World-Class Team
Graduates from top universities worldwide
🔬
Advanced R&D
Self-developed
🤖
Innovation Focus
Multiple innovative technologies

Our Products

View All Products →
Abemaciclib Intermediate

Abemaciclib Intermediate

Model: 4-Bromo-2,6-difluoroaniline 5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-amine 2-Bromo-5-formylpyridine 4-Fluoro-2-methyl-1-isopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
Parameters: 4-Bromo-2,6-difluoroaniline
CAS: 1868-81-7
Molecular Formula: C₆H₄BrF₂N
Molecular Weight: 207.91
Appearance: White to off-white crystalline solid
Purity: ≥98.0% (HPLC/GC)
Density: 1.768±0.06 g/cm³
Boiling Point: 239.4±35.0 °C
Melting Point: 57–61 °C
Storage: Sealed, dry, keep away from light at 2–8 °C
Application: Abemaciclib pharmaceutical intermediate

5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-amine
CAS: 398565-53-2
Molecular Formula: C₁₂H₂₀N₄
Molecular Weight: 220.03
Appearance: Off-white to light yellow solid
Purity: ≥98.0% (HPLC)
Boiling Point: 368.5±42.0 °C
Density: 1.124±0.06 g/cm³
Storage: Sealed, low temperature and light protection
Application: Key intermediate for Abemaciclib

2-Bromo-5-formylpyridine
CAS: 100422-52-6
Molecular Formula: C₆H₄BrNO
Molecular Weight: 185.91
Appearance: White to light yellow solid
Purity: ≥98.0% (GC/HPLC)
Melting Point: 78–82 °C
Boiling Point: 286.3±30.0 °C
Storage: Sealed, dry, refrigerated preservation
Application: Heterocyclic intermediate for Abemaciclib synthesis

4-Fluoro-2-methyl-1-isopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole
CAS: 1356339-86-7
Appearance: White to off-white solid
Purity: ≥98.0% (HPLC)
Storage: Sealed, inert gas protection, 2–8 °C, avoid light
Application: Boronic acid ester intermediate for Abemaciclib

6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
CAS: 1356339-85-6
Appearance: White to light beige solid
Purity: ≥98.0% (HPLC)
Storage: Sealed, dry, low temperature and light-proof storage
Application: Core benzimidazole intermediate for Abemaciclib R&D and production

Alectinib Intermediate

Alectinib Intermediate

Model: 2-(4-Ethylphenyl)-2-methylpropanoic acid 2-(4-Ethyl-3-iodophenyl)-2-methylpropanoic acid tert-Butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate
Parameters: 2-(4-Ethylphenyl)-2-methylpropanoic acid
CAS No.:1247119-83-0
Molecular Formula:C₁₂H₁₆O₂
Molecular Weight:192.26 g/mol
Appearance:White to off-white solid
Purity:≥98%
Density:1.047±0.06 g/cm³
Boiling Point:302.8±11.0 °C (760 mmHg)
Storage:2-8°C, sealed
Application:Alectinib intermediate


2-(4-Ethyl-3-iodophenyl)-2-methylpropanoic acid
CAS No.:1256584-73-2
Molecular Formula:C₁₂H₁₅IO₂
Molecular Weight:318.15 g/mol
Appearance:White to off-white solid
Purity:≥98%
Density:1.547±0.06 g/cm³
Boiling Point:369.6±27.0 °C (760 mmHg)
Storage:2-8°C, protect from light
Application:Alectinib intermediate


tert-Butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate
CAS No.:1256584-75-4
Molecular Formula:C₂₅H₂₇IN₂O₂
Molecular Weight:514.40 g/mol
Appearance:White to light yellow solid
Purity:≥98% (HPLC)
Storage:2-8°C, sealed, protect from light
Application:Alectinib key intermediate

Apalutamide Intermediate

Apalutamide Intermediate

Model: 2-Fluoro-4-nitrobenzoic acid N-Methyl-2-fluoro-4-nitrobenzamide N-Methyl-2-fluoro-4-aminobenzamide N-Methyl-2-fluoro-4-bromobenzamide Methyl 4-bromo-2-fluorobenzoate 2-Hydroxy-5-nitro-3-(trifluoromethyl)pyridine 5-Amino-3-(trifluoromethyl)pyridinecarbonitrile
Parameters: 2-Fluoro-4-nitrobenzoic acid
CAS: 403-24-7
Molecular Formula: C₇H₄FNO₄
Molecular Weight: 185.11
Appearance: White to light yellow solid
Melting Point: 170–176 °C
Boiling Point: 352.5±27 °C (predicted)
Density: 1.568±0.06 g/cm³ (predicted)
Purity: ≥98.0%
Storage: Sealed, dry, stored at room temperature

N-Methyl-2-fluoro-4-nitrobenzamide
CAS: 915087-24-0
Molecular Formula: C₈H₇FN₂O₃
Molecular Weight: 198.15
Appearance: Light yellow to yellow solid
Melting Point: Unavailable
Boiling Point: 337.1±32 °C (predicted)
Density: 1.358 g/cm³
Purity: ≥98.0% (HPLC)
Storage: Sealed, dry, stored at room temperature

N-Methyl-2-fluoro-4-aminobenzamide
CAS: 915087-25-1
Molecular Formula: C₈H₉FN₂O
Molecular Weight: 168.17
Appearance: Off-white solid
Melting Point: 160–163 °C
Boiling Point: Approx. 320 °C (estimated)
Density: Unavailable
Purity: ≥98.0% (HPLC)
Storage: Sealed, dry, stored at room temperature

N-Methyl-2-fluoro-4-bromobenzamide
CAS: 749927-69-3
Molecular Formula: C₈H₇BrFNO
Molecular Weight: 232.05
Appearance: White crystalline powder
Melting Point: Unavailable
Boiling Point: 284.8±30 °C
Density: 1.545±0.06 g/cm³
Purity: ≥98.0% (HPLC)
Storage: Sealed, dry, stored at room temperature

Methyl 4-bromo-2-fluorobenzoate
CAS: 179232-29-2
Molecular Formula: C₈H₆BrFO₂
Molecular Weight: 233.03
Appearance: White to off-white solid
Melting Point: 58–62 °C
Boiling Point: 272.7±25 °C
Density: 1.577±0.06 g/cm³
Purity: ≥98.0% (GC)
Storage: Sealed, dry, stored at room temperature

2-Hydroxy-5-nitro-3-(trifluoromethyl)pyridine
CAS: 99368-66-8
Molecular Formula: C₆H₃F₃N₂O₃
Molecular Weight: 208.09
Appearance: Light yellow solid
Melting Point: 158 °C
Boiling Point: 276.2±40 °C (predicted)
Density: 1.61±0.1 g/cm³ (predicted)
Purity: ≥97%~≥98%
Storage: Sealed, dry, stored at room temperature

5-Amino-3-(trifluoromethyl)pyridinecarbonitrile
CAS: 573762-62-6
CAS: 573762-62-6
Molecular Formula: C₇H₄F₃N₃
Molecular Weight: 187.12
Appearance: Off-white to yellow solid
Melting Point: Unavailable
Boiling Point: 362.2±42 °C (predicted)
Density: 1.45±0.1 g/cm³ (predicted)
Purity: ≥97%~≥99.0%
Storage: Keep away from light, stored at room temperature under inert atmosphere

Company Gallery

Certifications & Awards

Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
ISO 9001:2015 Quality Management System Certificate
ISO 9001:2015 Quality Management System Certificate

Success Stories & Case Studies

Top-tier Pharmaceutical Group

Top-tier Pharmaceutical Group

1High reaction yield reduces the production cost of finished pharmaceuticals.
2Low levels of impurities, heavy metals and residual solvents minimize drug safety risks.
3Stable quality across batches improves the consistency of customers’ pharmaceutical production.
4Simplified downstream synthesis processes shorten drug development cycles.
5Accelerates the drug registration process.
Ultra‑high purity with strictly controlled impurities, heavy metals and residual solvents.
Consistent quality batch‑to‑batch, stable crystal form and particle size.
Strict compliance with ICH, GMP and international pharmaceutical standards.
Stable large‑scale production capacity and reliable supply chain.
Customizable R&D support for API synthesis and drug registration.

📍 Location: US,AE,AU,BD,CA,CN,DE,FR,KR,SA,GB,IN,SG,SE 📦 Quantity: 200

Company & Product Videos

Company Introduction & Factory Tour

⏱ Duration: 3:45 | 👁 Views: 15,230

Product Demonstration - Kestrel K-1

⏱ Duration: 5:12 | 👁 Views: 28,450

Technology Innovation Showcase

⏱ Duration: 4:30 | 👁 Views: 12,890

Customer Testimonials & Success Stories

⏱ Duration: 6:20 | 👁 Views: 9,650

Ready to Transform Your Life?

Contact us immediately to learn how our products meet your needs.